Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials.

The malaria parasite feeds by degrading haemoglobin in an acidic food vacuole, producing free haem moieties as a by-product. The haem in oxyhaemoglobin is oxidized from the Fe(II) state to the Fe(III) state with the consequent production of an equimolar concentration of H2O2. We have analysed the fate of haem molecules in Plasmodium falciparum-infected erythrocytes and have found that only about one third of the haem is polymerized to form haemozoin. The remainder appears to be degraded by a non-enzymic process which leads to an accumulation of iron in the parasite. A possible route for degradation of the haem is by reacting with H2O2, and we show that, under conditions designed to resemble those found in the food vacuole, i.e., at pH5.2 in the presence of protein, free haem undergoes rapid peroxidative decomposition. Chloroquine and quinacrine are shown to be efficient inhibitors of the peroxidative destruction of haem, while epiquinine, a quinoline compound with very low antimalarial activity, has little inhibitory effect. We also show that chloroquine enhances the association of haem with membranes, while epiquinine inhibits this association, and that treatment of parasitized erythrocytes with chloroquine leads to a build-up of membrane-associated haem in the parasite. We suggest that chloroquine exerts its antimalarial activity by causing a build-up of toxic membrane-associated haem molecules that eventually destroy the integrity of the malaria parasite. We have further shown that resistance-modulating compounds, such as chlorpromazine, interact with haem and efficiently inhibit its degradation. This may explain the weak antimalarial activities of these compounds.

[1]  H. Sprinz,et al.  Morphological Effects of Chloroquine on Plasmodium berghei in Mice , 1967, Nature.

[2]  S. B. Brown,et al.  Catalatic activity of iron(3)-centred catalysts. Role of dimerization in the catalytic action of ferrihaems. , 1970, The Biochemical journal.

[3]  P Carter,et al.  Spectrophotometric determination of serum iron at the submicrogram level with a new reagent (ferrozine). , 1971, Analytical biochemistry.

[4]  Specific immunoassay for quantitative determination of human erythrocyte catalase. , 1973, The Journal of laboratory and clinical medicine.

[5]  C. D. Fitch,et al.  High-affinity accumulation of chloroquine by mouse erythrocytes infected with Plasmodium berghei. , 1974, Journal of Clinical Investigation.

[6]  R. Carrell,et al.  Activated oxygen and haemolysis. , 1975, British journal of haematology.

[7]  Samir K. Srivastava,et al.  Purification and properties of human erythrocyte glutathione peroxidase. , 1975, The Journal of biological chemistry.

[8]  J. Eaton,et al.  Host heme catabolism in drug-sensitive and drug-resistant malaria. , 1977, The Journal of laboratory and clinical medicine.

[9]  K. Adachi,et al.  Denatured hemoglobin in sickle erythrocytes. , 1977, The Journal of clinical investigation.

[10]  The role of peroxide in haem degradation. A study of the oxidation of ferrihaems by hydrogen peroxide. , 1978, The Biochemical journal.

[11]  S. B. Brown,et al.  Catalase model systems. Decomposition of hydrogen peroxide catalysed by mesoferrihaem, deuteroferrihaem, coproferrihaem and haematoferrihaem. , 1978, The Biochemical journal.

[12]  A. Chou,et al.  Ferriprotoporphyrin IX fulfills the criteria for identification as the chloroquine receptor of malaria parasites. , 1980, Biochemistry.

[13]  D. Warhurst,et al.  The quinine-haemin interaction and its relationship to antimalarial activity. , 1981, Biochemical pharmacology.

[14]  A. Riggs [1] Preparation of blood hemoglobins of vertebrates , 1981 .

[15]  W. Caughey,et al.  Mechanism of autooxidation for hemoglobins and myoglobins. Promotion of superoxide production by protons and anions. , 1982, The Journal of biological chemistry.

[16]  [Interaction of chloroquine with ferriprotophorphyrin IX. Nuclear magnetic resonance study]. , 1982, Biochimie.

[17]  H. Ginsburg,et al.  Effects of chloroquine on the feeding mechanism of the intraerythrocytic human malarial parasite Plasmodium falciparum. , 1984, The Journal of protozoology.

[18]  H. Ginsburg,et al.  Identification of the acidic compartment of Plasmodium falciparum‐infected human erythrocytes as the target of the antimalarial drug chloroquine. , 1984, The EMBO journal.

[19]  H. Ginsburg,et al.  Interactions of hemin, antimalarial drugs and hemin-antimalarial complexes with phospholipid monolayers. , 1984, Chemistry and physics of lipids.

[20]  U. Muller-eberhard,et al.  Kinetics of the interaction of hemin liposomes with heme binding proteins. , 1984, Biochemistry.

[21]  K. Marsh,et al.  Identification of isolate-specific proteins on sorbitol-enriched Plasmodium falciparum infected erythrocytes from Gambian patients , 1986, Parasitology.

[22]  M. Nakano,et al.  A ferriprotoporphyrin IX‐chloroquine complex promotes membrane phospholipid peroxidation A possible mechanism for antimalarial action , 1987, FEBS letters.

[23]  Y. Zhang,et al.  Lysis of malarial parasites and erythrocytes by ferriprotoporphyrin IX-chloroquine and the inhibition of this effect by proteins. , 1987, Biochemical pharmacology.

[24]  W. Milhous,et al.  Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. , 1987, Science.

[25]  J. Eaton,et al.  Oxidant defense enzymes of Plasmodium falciparum. , 1988, Molecular and biochemical parasitology.

[26]  A. Bitonti,et al.  Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum by desipramine. , 1988, Science.

[27]  R. Stocker,et al.  Oxidative stress and the redox status of malaria-infected erythrocytes. , 1990, Blood cells.

[28]  J. Le bras,et al.  Potentiation of chloroquine activity against Plasmodium falciparum by the peroxidase-hydrogen peroxide system , 1990, Antimicrobial Agents and Chemotherapy.

[29]  H. Ginsburg,et al.  Kinetic modelling of the response of Plasmodium falciparum to chloroquine and its experimental testing in vitro. Implications for mechanism of action of and resistance to the drug. , 1990, Biochemical pharmacology.

[30]  M. Fischer,et al.  Oxidation of chlorpromazine by methemoglobin in the presence of hydrogen peroxide. Formation of chlorpromazine radical cation and its covalent binding to methemoglobin. , 1991, Archives of biochemistry and biophysics.

[31]  D. Goldberg,et al.  An iron-carboxylate bond links the heme units of malaria pigment. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[32]  I. Kimata,et al.  Ultrastructural changes associated with reversal of chloroquine resistance by verapamil in Plasmodium chabaudi , 1991, Parasitology.

[33]  A. Cerami,et al.  Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites , 1992, Nature.

[34]  H. Ginsburg,et al.  Origin of reactive oxygen species in erythrocytes infected with Plasmodium falciparum. , 1993, Molecular and biochemical parasitology.

[35]  J W Eaton,et al.  Hemoglobin catabolism and host-parasite heme balance in chloroquine-sensitive and chloroquine-resistant Plasmodium berghei infections. , 1993, The American journal of tropical medicine and hygiene.

[36]  A. Chou,et al.  Control of heme polymerase by chloroquine and other quinoline derivatives. , 1993, Biochemical and biophysical research communications.

[37]  D. Kyle,et al.  Reversal of Plasmodium falciparum resistance to chloroquine in Panamanian Aotus monkeys. , 1993, The American journal of tropical medicine and hygiene.

[38]  Falciparum malaria in naturally infected human patients: VIII. Fine structure of intraerythrocytic asexual forms before and during chloroquine treatment. , 1994 .

[39]  A. Cerami,et al.  Verapamil Reversal of Chloroquine Resistance in the Malaria Parasite Plasmodium falciparum Is Specific for Resistant Parasites and Independent of the Weak Base Effect (*) , 1995, The Journal of Biological Chemistry.

[40]  H. Matile,et al.  Malarial haemozoin/β-haematin supports haem polymerization in the absence of protein , 1995, Nature.

[41]  D. Platel,et al.  Plasmodium berghei: implication of intracellular glutathione and its related enzyme in chloroquine resistance in vivo. , 1995, Experimental parasitology.

[42]  A. Cowman,et al.  Synthesis and activity of some antimalarial bisquinolines. , 1995, Journal of medicinal chemistry.

[43]  D. Sullivan,et al.  Plasmodium Hemozoin Formation Mediated by Histidine-Rich Proteins , 1996, Science.

[44]  T. Egan,et al.  The iron environment in heme and heme-antimalarial complexes of pharmacological interest. , 1996, Journal of inorganic biochemistry.

[45]  M. Foley,et al.  Novel bisquinoline antimalarials. Synthesis, antimalarial activity, and inhibition of haem polymerisation. , 1996, Biochemical pharmacology.

[46]  B. Gamain,et al.  Molecular characterization of the glutathione peroxidase gene of the human malaria parasite Plasmodium falciparum. , 1996, Molecular and biochemical parasitology.

[47]  P. Rosenthal,et al.  Hemoglobin catabolism and iron utilization by malaria parasites. , 1996, Molecular and biochemical parasitology.

[48]  S. Wünsch,et al.  Identification of a Chloroquine Importer in Plasmodium falciparum , 1997, The Journal of Biological Chemistry.

[49]  K. Kuželová,et al.  Kinetics of heme interaction with heme-binding proteins: the effect of heme aggregation state. , 1997, Biochimica et biophysica acta.

[50]  G. Blauer,et al.  Investigations of B- and β-hematin , 1997 .

[51]  S. Mueller,et al.  Direct evidence for catalase as the predominant H2O2 -removing enzyme in human erythrocytes. , 1997, Blood.

[52]  S. Ward,et al.  Quinoline resistance mechanisms in Plasmodium falciparum: the debate goes on , 1997, Parasitology.

[53]  M. Foley,et al.  Identification of an endoplasmic reticulum-resident calcium-binding protein with multiple EF-hand motifs in asexual stages of Plasmodium falciparum. , 1997 .

[54]  S. Ward,et al.  Access to hematin: the basis of chloroquine resistance. , 1998, Molecular pharmacology.

[55]  M. Foley,et al.  Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents. , 1998, Pharmacology & therapeutics.